Is Fascial Manipulation painful? The treatment itself should not be acutely painful — though deep fascial work can be uncomfortable in the moment, particularly over a densified area. What many people do experience is mild soreness in the treated region that develops in the hours after a session. This is a normal and expected response, and the research now offers a proposed molecular explanation for why it happens.
The natural interpretation is that something was damaged, or that the treatment was too forceful. A 2023 narrative review by Stecco and colleagues — published in the journal Life — proposes a specific molecular explanation for this soreness that challenges that interpretation entirely. [1] Rather than a side effect of treatment, the inflammatory response appears to be a necessary phase of the tissue restoration process: the mechanism itself, not a complication of it.
The Molecule at the Centre of It
Understanding the soreness requires understanding what Fascial Manipulation is acting on.
In the loose connective tissue between fascial layers — the thin, lubricated interfaces that allow adjacent structures to glide freely during movement — sits a molecule called hyaluronan (HA). HA is a glycosaminoglycan found throughout the body's connective tissues. In its healthy state, it exists as a long, high-molecular-weight polymer that gives the interfascial space its normal lubricating, viscoelastic properties. It allows the layers to slide.
When HA undergoes a shift in molecular weight — fragmenting from its normal long-chain form into progressively smaller pieces — the interfascial space changes character. Medium-molecular-weight fragments increase viscosity. Low-molecular-weight fragments become biologically active in a very different way: rather than lubricating, they trigger an inflammatory response. In the Stecco densification model, the accumulation of self-aggregated, high-viscosity HA in the interfascial loose connective tissue — palpable as the stiff, resistant tissue quality the treating hand works with — restricts gliding and alters load distribution across the fascial system.
Fascial Manipulation applies deep, sustained friction at specific anatomical points to generate the local mechanical and thermal conditions that can disrupt this aggregated HA. The question this 2023 paper addresses is: what happens at the molecular level when it does?
The Inflammatory Cascade: What the Research Proposes
Stecco and colleagues reviewed 44 studies examining the relationship between mechanical stress, hyaluronan fragmentation, and the resulting inflammatory response in connective tissues. [1]
Their proposed mechanism proceeds in steps.
Deep friction generates mechanical stress in the interfascial tissue. This depolymerises the self-aggregated, high-molecular-weight HA chains into progressively smaller fragments. The early products of this fragmentation — low-molecular-weight HA (LMW HA, ≤500 kDa) — are biologically active: they bind to TLR-4 and CD44 receptors on local cells, triggering the release of pro-inflammatory mediators including TNF-α, IL-1β, and matrix metalloproteinases. This is the beginning of the inflammatory cascade that patients perceive as post-treatment soreness.
A 2025 mechanobiology review by Kirkness and Scarlata identifies the upstream molecular trigger for this process. [3] Mechanical deformation activates calcium ion channels on fasciacyte membranes — Piezo1, TRPV4, and P2Y2 receptors — initiating a calcium influx that drives HAS2-mediated HA synthesis. The molecular weight of newly synthesised HA then determines what happens next: high-molecular-weight HA (HMW-HA) binds CD44 receptors to restore homeostasis and downregulate mechanosensitivity (the “Quiet” state), while LMW fragments — the same fragments produced by treatment-driven depolymerisation of aggregated HA — bind RHAMM receptors, amplifying the TLR-4/CD44 inflammatory signalling (the “Riot” state). This CD44/RHAMM oscillation provides the molecular framework for understanding why fragmentation is a necessary precursor to restoration: the system must pass through a controlled pro-remodelling state before homeostasis can be re-established. [3]
The paper proposes a time course for this cascade. In its model, inflammatory activity and the associated soreness peak at around 12 hours. From that point the cascade becomes self-resolving: the smallest products of HA fragmentation — oligosaccharides (o-HA, <10 kDa) — have the opposite biological effect of their larger predecessors. Rather than amplifying inflammation, oligomeric HA inhibits the inflammatory response and facilitates cellular resolution. By 24 to 48 hours, in most cases, the inflammatory phase has resolved and a new, physiologically appropriate HA environment has been established in the treated region.
In practice, the timing varies more than that model suggests. The same paper reports soreness lasting anywhere from one to three days, and occasionally longer, and in our clinical experience it is often most noticeable around the next day.
Why the Cascade Appears to Be Necessary, Not Incidental
The significance of this mechanism is not just that it explains soreness. It is that the inflammatory process appears to be required for the durable restoration of normal interfascial tissue properties.
The self-assembled, aggregated HA that characterises a densification cannot simply be cleared from the tissue intact. It must first be fragmented into smaller pieces that can be drained via the lymphatic system and metabolised. Once that clearance has occurred, the fasciacytes — specialised cells in the interfascial loose connective tissue whose primary function is HA synthesis and homeostasis — can replace the fragmented HA with new, correctly sized, physiologically appropriate polymer. Normal interfascial gliding can resume.
Without the fragmentation cascade to initiate this process, the long-chain self-assembled HA remains in the tissue. This is why, Stecco and colleagues propose, the soreness that follows deep friction treatment should be understood as a functional signal — indicating that the restoration process has been initiated — rather than evidence that something has gone wrong.
The intensity and duration of the cascade is not fixed. According to the proposed model, it scales with the degree of pre-existing HA accumulation: the more chronic the densification, the more aggregated HA is present, and the more substantial the inflammatory phase required to clear it. A region that has been restricted for months or years may produce a more noticeable post-treatment response than an acute restriction addressed early.
The NSAIDs Question
This mechanism has a direct clinical implication worth stating plainly.
Non-steroidal anti-inflammatory drugs (NSAIDs) — ibuprofen, naproxen, diclofenac — work by suppressing the inflammatory cascade. If this cascade is part of how the tissue responds to treatment, suppressing it with NSAIDs in the post-treatment period may work against the change the treatment aims for.
Paracetamol (acetaminophen) relieves pain without meaningful anti-inflammatory action, so it is less likely to interfere with this process. [1]
This is not a minor footnote. It directly informs the advice given to patients before and after a session of Fascial Manipulation or any deep friction manual therapy.
What the MRI Evidence Adds
The Stecco 2023 paper addresses the molecular mechanism of why soreness occurs. A 2020 MRI study from NYU School of Medicine and Johns Hopkins, examined in detail in our MRI evidence post, looked for that outcome on imaging. After three sessions of Fascial Manipulation, unbound water in the deep fascia fell in the most severe of four patients rescanned, consistent with a reduction in HA viscosity, but rose in the other three. [2] The authors call their data preliminary.
Together, these papers sketch a proposed process; neither establishes it. The Stecco 2023 mechanism proposes how the change occurs — HA fragmentation drives an inflammatory cascade that clears the aggregated HA and initiates restoration. The Menon 2020 MRI study shows that a change of this kind can be measured in living fascia, although in that small study it appeared in only one of four patients. On this account, the soreness in between would be the visible surface of a molecular process.
What This Means for You
If you feel sore after a session of Fascial Manipulation or deep friction manual therapy, the proposed mechanism suggests this is a functional response to treatment — not damage. The soreness is often most noticeable around the next day, and typically settles within one to three days.
If you have had chronic, long-standing restrictions treated, the post-treatment response may be more noticeable. This is consistent with the model: more accumulated HA requires more fragmentation and a more substantial clearing process.
Ibuprofen and other NSAIDs are best avoided in the immediate post-treatment period unless you need them for another reason, as they may interfere with the inflammatory process that underlies the tissue change the treatment aims to achieve. If you need something for pain, paracetamol is less likely to interfere, but check with your pharmacist or GP first, particularly if you take other medications. Never stop or change prescribed medication — including low-dose aspirin taken for heart or stroke prevention — without speaking to your GP or pharmacist.
If you feel like moving gently after treatment, the research supports it. Light activity generates local heat and promotes lymphatic flow, both of which may support HA fragmentation and drainage. There is no need to rest completely — gentle movement in the treated region is appropriate and encouraged.
If your soreness persists beyond 72 hours or is significantly more intense than expected, let us know. While some variability is normal and expected, marked or prolonged soreness warrants a conversation about treatment parameters.
If you are wondering whether age or hormonal history might affect your post-treatment response, Kodama and colleagues (2023) document that lumbar fascial tissue thickens progressively with age — up to 40–77% greater in older cohorts compared with younger controls — while estrogen receptor β activity normally inhibits TGF-β expression and the fibroblast-to-myofibroblast conversion that drives structural fascial change. [4] Prolonged estrogen deficiency may therefore be associated with a greater degree of accumulated fascial change and a correspondingly more noticeable post-treatment response as that accumulated change is worked through. This is consistent with clinical observation and one reason why age and hormonal history are useful context in a thorough fascial assessment.
Want to know what to expect from your first session? Read our new patients guide →
References
- PubMed Stecco A, Bonaldi L, Fontanella CG, Stecco C, Pirri C (2023). The Effect of Mechanical Stress on Hyaluronan Fragments' Inflammatory Cascade: Clinical Implications. Life, 13(12), 2277.
- PubMed Menon RG, Oswald SF, Raghavan P, Regatte RR, Stecco A (2020). T1ρ-Mapping for Musculoskeletal Pain Diagnosis: Case Series of Variation of Water Bound Glycosaminoglycans Quantification before and after Fascial Manipulation® in Subjects with Elbow Pain. International Journal of Environmental Research and Public Health, 17(3), 708.
- PubMed Kirkness KB, Scarlata S (2025). Understanding fascial tissue on the molecular level — how its unique properties enable adaptation or dysfunction. International Journal of Molecular Sciences, 27, 160.
- PubMed Kodama Y, Masuda S, Ohmori T, Kanamaru A, Tanaka M, Sakaguchi T, Nakagawa M (2023). Response to mechanical properties and physiological challenges of fascia: diagnosis and rehabilitative therapeutic intervention for myofascial system disorders. Bioengineering, 10, 474.
